Tuesday, 29 March 2011 10:46

MedNet Solutions To Unveil iMedNet EDC At The 2011 Partnerships In Clinical Trials Conference

MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, is pleased to announce that it will officially unveil iMedNet™ EDC, the company’s innovative, next‐generation electronic data capture (EDC) solution, at the upcoming Partnerships in Clinical Trials conference in Phoenix, AZ. Demonstrations of MedNet Solutions’ full lineup of eClinical solutions, including iMedNet EDC, will be held in MedNet’s booth (#918) at the Phoenix Convention Center on Wednesday, March 30 through Friday, April 1.

Built from the ground up, and based on MedNet Solutions’ 10+ years of experience developing proven eClinical systems, iMedNet EDC delivers a practical, affordable and easy‐to‐use cloud‐based solution that allows non‐technical research personnel to rapidly  build their own clinical research studies. iMedNet EDC’s software‐as‐a‐service (SaaS) pricing model dramatically lowers technology‐related costs, making it an ideal solution for studies of any kind, including Phase I‐IV trials, feasibility studies, registries and investigator initiated research.

“We are extremely excited to introduce the commercially available version of iMedNet EDC at Partnerships,” stated John M. (Rob) Robertson, President and CEO of MedNet Solutions. “We have numerous CROs and Sponsors who have seen initial iMedNet product demonstrations and are anxious to begin using it to build, deploy and manage their upcoming research initiatives. We know they  won’t be disappointed.”

About MedNet Solutions
MedNet Solutions is a leading healthcare technology company specializing in clinical study management systems designed for the global life sciences market. Applying critical insight, proven technology and unwavering support, MedNet delivers powerful, flexible and easy‐to‐use web‐based solutions that support our customers’ clinical studies, registries and investigator initiated trials. Since 2000, MedNet has successfully supported leading pharmaceutical, medical device, biotechnology, and clinical research organizations on projects spanning 6 continents and more than 40 countries. MedNet delivers a superior customer experience from beginning to end. For more information, please visit www.mednetstudy.com.
Read 1044 times

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

Want more? Visit...

Videos

  • ICON- Partnerships 12
    ICON- Partnerships 12 Steven Cutler, Group President of ICON discusses the launch of ICON's new acquisition of Firecrest at Partnerships in Clinical Trials 2012. Facing the continuing challenge of not only monitoring and…
    Read more...
  • ICON- Partnerships 12
    ICON- Partnerships 12 Steven Cutler, Group President of ICON discusses their exciting new partnership with Roche at Partnerships In Clinical Trials 2012. Medical imaging has always been a strong department within ICON. ICON…
    Read more...
  • ERT- Partnerships 12
    ERT- Partnerships 12 John Blakely, Executive Vice President and Chief Commercial Officer for ERT discusses the new trend in clinical research at Partnerships in Clinical Trials 2012 - the melding of objective and…
    Read more...
  • Chiltern- Partnerships 12
    Chiltern- Partnerships 12 Marcelo Piccirillo, Senior Clinical Research Physician for Chiltern, discusses new trends in gastrointestinal clinical development at Partnerships in Clinical Trials 2012. Current hot spots for clinical development in the field…
    Read more...
  • Blinded Diagnostics - Partnerships 12
    Blinded Diagnostics - Partnerships 12 Paul Savuto, President and CFO, and Steven Karrupan, CEO, from Blinded Diagnostics discuss Point of Care Technology at Partnerships in Clinical Trials 2012. Point of care (or decentralized testing) offers…
    Read more...
  • American Airlines - IQPC 2011
    American Airlines - IQPC 2011 American Airlines has globally launched a passive solutions that gives a new alternative to pharmaceutical manufacturers.
    Read more...

Podcasts